Authors: YOKEL RA MEURER KA HONG CB DICKEY KM SKINNER TL FREDENBURG AM

Citation: Ra. Yokel et al., SHORT-TERM ORAL 3-HYDROXYPYRIDIN-4-ONE DOSING INCREASES ALUMINUM EXCRETION AND PARTIALLY REVERSES ALUMINUM-INDUCED TOXICITY IN THE RABBIT INDEPENDENT OF CHELATOR LIPOPHILICITY, Drug metabolism and disposition, 25(2), 1997, pp. 182-190

Authors: FREDENBURG AM SETHI RK ALLEN DD YOKEL RA

Citation: Am. Fredenburg et al., THE PHARMACOKINETICS AND BLOOD-BRAIN-BARRIER PERMEATION OF THE CHELATORS 1,2-DIMETHYL-HYDROXYPYRIDIN-4-ONE, 1,2-DIETHYL-HYDROXYPYRIDIN-4-ONE, AND 1-[ETHAN-1'OL]-2-METHYL-3-HYDROXYPYRIDIN-4-ONE IN THE RAT, Toxicology, 108(3), 1996, pp. 191-199

Authors: YOKEL RA MEURER KA SKINNER TL FREDENBURG AM

Citation: Ra. Yokel et al., THE 3-HYDROXYPYRIDIN-4-ONES MORE EFFECTIVELY CHELATE ALUMINUM IN A RABBIT MODEL OF ALUMINUM INTOXICATION THAN DOES DESFERRIOXAMINE, Drug metabolism and disposition, 24(1), 1996, pp. 105-111

Authors: YOKEL RA FREDENBURG AM MEURER KA SKINNER TL

Citation: Ra. Yokel et al., INFLUENCE OF LIPOPHILICITY ON THE BIOAVAILABILITY AND DISPOSITION OF ORALLY-ACTIVE 3-HYDROXYPYRIDIN-4-ONE METAL CHELATORS, Drug metabolism and disposition, 23(10), 1995, pp. 1178-1180